Journal: EBioMedicine / Year: 2024 Title: Integrating artificial intelligence-based epitope prediction in a SARS-CoV-2 antibody discovery pipeline: caution is warranted. Authors: Delphine Diana Acar / Wojciech Witkowski / Magdalena Wejda / Ruifang Wei / Tim Desmet / Bert Schepens / Sieglinde De Cae / Koen Sedeyn / Hannah Eeckhaut / Daria Fijalkowska / Kenny Roose / ...Authors: Delphine Diana Acar / Wojciech Witkowski / Magdalena Wejda / Ruifang Wei / Tim Desmet / Bert Schepens / Sieglinde De Cae / Koen Sedeyn / Hannah Eeckhaut / Daria Fijalkowska / Kenny Roose / Sandrine Vanmarcke / Anne Poupon / Dirk Jochmans / Xin Zhang / Rana Abdelnabi / Caroline S Foo / Birgit Weynand / Dirk Reiter / Nico Callewaert / Han Remaut / Johan Neyts / Xavier Saelens / Sarah Gerlo / Linos Vandekerckhove / Abstract: BACKGROUND: SARS-CoV-2-neutralizing antibodies (nABs) showed great promise in the early phases of the COVID-19 pandemic. The emergence of resistant strains, however, quickly rendered the majority of ...BACKGROUND: SARS-CoV-2-neutralizing antibodies (nABs) showed great promise in the early phases of the COVID-19 pandemic. The emergence of resistant strains, however, quickly rendered the majority of clinically approved nABs ineffective. This underscored the imperative to develop nAB cocktails targeting non-overlapping epitopes. METHODS: Undertaking a nAB discovery program, we employed a classical workflow, while integrating artificial intelligence (AI)-based prediction to select non-competing nABs very early in the pipeline. ...METHODS: Undertaking a nAB discovery program, we employed a classical workflow, while integrating artificial intelligence (AI)-based prediction to select non-competing nABs very early in the pipeline. We identified and in vivo validated (in female Syrian hamsters) two highly potent nABs. FINDINGS: Despite the promising results, in depth cryo-EM structural analysis demonstrated that the AI-based prediction employed with the intention to ensure non-overlapping epitopes was inaccurate. ...FINDINGS: Despite the promising results, in depth cryo-EM structural analysis demonstrated that the AI-based prediction employed with the intention to ensure non-overlapping epitopes was inaccurate. The two nABs in fact bound to the same receptor-binding epitope in a remarkably similar manner. INTERPRETATION: Our findings indicate that, even in the Alphafold era, AI-based predictions of paratope-epitope interactions are rough and experimental validation of epitopes remains an essential ...INTERPRETATION: Our findings indicate that, even in the Alphafold era, AI-based predictions of paratope-epitope interactions are rough and experimental validation of epitopes remains an essential cornerstone of a successful nAB lead selection. FUNDING: Full list of funders is provided at the end of the manuscript.
Entire : Complex of SARS-CoV2 S Protein (Wuhan) and FAB fragment of neutra...
Entire
Name: Complex of SARS-CoV2 S Protein (Wuhan) and FAB fragment of neutralising human antibody UZGENT_A3
Components
Complex: Complex of SARS-CoV2 S Protein (Wuhan) and FAB fragment of neutralising human antibody UZGENT_A3
Complex: SARS-CoV2 S Protein with Fibritin (trimerization) tag
Protein or peptide: Spike glycoprotein,Fibritin
Complex: FAB fragment of neutralising human antibody UZGENT_A3
Protein or peptide: IgG light chain - FAB
Protein or peptide: IgG heavy chain - FAB
Ligand: 2-acetamido-2-deoxy-beta-D-glucopyranose
-
Supramolecule #1: Complex of SARS-CoV2 S Protein (Wuhan) and FAB fragment of neutra...
Supramolecule
Name: Complex of SARS-CoV2 S Protein (Wuhan) and FAB fragment of neutralising human antibody UZGENT_A3 type: complex / ID: 1 / Parent: 0 / Macromolecule list: #2-#3
-
Supramolecule #2: SARS-CoV2 S Protein with Fibritin (trimerization) tag
Supramolecule
Name: SARS-CoV2 S Protein with Fibritin (trimerization) tag / type: complex / ID: 2 / Parent: 1 / Macromolecule list: #1
Source (natural)
Organism: Severe acute respiratory syndrome coronavirus 2
-
Supramolecule #3: FAB fragment of neutralising human antibody UZGENT_A3
Supramolecule
Name: FAB fragment of neutralising human antibody UZGENT_A3 / type: complex / ID: 3 / Parent: 1 / Macromolecule list: #2-#3
Source (natural)
Organism: Homo sapiens (human)
-
Macromolecule #1: Spike glycoprotein,Fibritin
Macromolecule
Name: Spike glycoprotein,Fibritin / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi